✦ LIBER ✦

Commentary on “Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)”

✍ Scribed by Raymond P. Abratt

Book ID: 114412004
Publisher: CIG Media Group, LP.
Year: 2002
Tongue: English
Weight: 61 KB
Volume: 3
Category: Article
ISSN: 1525-7304
DOI: 10.1016/s1525-7304(11)70644-1

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Novel Doublets in Extensive-Stage Small-

Novel Doublets in Extensive-Stage Small-Cell Lung Cancer: A Randomized Phase II Study of Topotecan Plus Cisplatin or Paclitaxel (CALGB 9430)

✍ Alan P. Lyss; James E. Herndon II; Thomas J. Lynch Jr; Andrew T. Turrisi; Doroth 📂 Article 📅 2002 🏛 CIG Media Group, LP. 🌐 English ⚖ 141 KB

Randomized, phase II study of topotecan/

Randomized, phase II study of topotecan/paclitaxel versus cisplatin/etoposide in patients with untreated, extensive disease, small cell lung cancer (SCLC)

✍ H. Lena; J. Breton; W. Yu; K. Steppert; K. Lightcap; G. Ross; M. Lymboura 📂 Article 📅 2001 🏛 Elsevier Science 🌐 English ⚖ 169 KB

Cisplatin — Paclitaxel — Topotecan (CPT)

Cisplatin — Paclitaxel — Topotecan (CPT) weekly administration in chemo-naive or pretreated extensive disease small cell lung cancer (ED-SCLC). A SICOG Phase II study

✍ N. Panza; G. Frasci; P. Comella; G. Nicolella; M. Natale; D. Muci; S. Palmeri; P 📂 Article 📅 1999 🏛 Elsevier Science 🌐 English ⚖ 156 KB

Sequential administration of cisplatin–e

Sequential administration of cisplatin–etoposide followed by topotecan in patients with extensive stage small cell lung cancer. A multicenter phase II study

✍ Mavroudis, D; Pavlakou, G; Blazoyiannakis, G; Veslemes, M; Apostolopoulou, F; Ko 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 104 KB

Alternating chemotherapy with etoposide

Alternating chemotherapy with etoposide plus cisplatin and topotecan plus paclitaxel in patients with untreated, extensive-stage small cell lung carcinoma : A Phase II trial of the North Central Cancer Treatment Group

✍ James R. Jett; Alan K. Hatfield; Shauna Hillman; Michael D. Bauman; James A. Mai 📂 Article 📅 2003 🏛 John Wiley and Sons 🌐 English ⚖ 83 KB 👁 3 views

## Abstract ## BACKGROUND The objective of this study was to test the response rate and toxicity of alternating chemotherapy in previously untreated patients with extensive‐stage small cell lung carcinoma (SCLC). ## METHODS Patients with histologically proven, extensive‐stage SCLC, with a perfor

Randomized phase II study comparing topo

Randomized phase II study comparing topotecan/cisplatin administration for 5 days versus 3 days in the treatment of extensive stage small cell lung cancer (SCLC)

✍ Seifart, U.; Jensen, K.; Ukena, J.; Mueller, C.; Schröder, M.; Fuhr, H.G.; Keppl 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 166 KB